DEERFIELD MANAGEMENT COMPANY, L.P.: COGENT BIOSCIENCES INC (COGT): Quarterly 13F Position History
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. reported 5,006,104 shares of COGENT BIOSCIENCES INC (COGT), worth $193.7M and representing 2.0% of its 13F equity book. Quarter-over-quarter share count change: 4,037,799 (-44.6%) . The position first appeared in Q4 2020 and has been disclosed across 23 13F-HR filings in Pactolio's tracked window.
- 5,006,104Shares Held (Latest Filing)
- $193.7MReported Market Value (Latest Filing)
- 2.0%Portfolio Weight (% of 13F Equity Book)
- 4,037,799Quarter-over-Quarter Share Change
- -$154.4MQuarter-over-Quarter Value Change
- 9,053,118Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 23 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,006,104 | 4,037,799 | -44.6% | $193.7M | 2.0% | $38.7 |
| Q1 2026 | 9,043,903 | 0 | – | $348.1M | 4.1% | $38.5 |
| Q4 2025 | 9,043,903 | 9,215 | -0.1% | $321.2M | 4.1% | $35.5 |
| Q3 2025 | 9,053,118 | +6,412,903 | +242.9% | $130.0M | 2.0% | $14.4 |
| Q2 2025 | 2,640,215 | +6,353 | +0.2% | $19.0M | 0.3% | $7.2 |
| Q1 2025 | 2,633,862 | +2,862 | +0.1% | $15.8M | 0.3% | $6.0 |
| Q4 2024 | 2,631,000 | 1,113,263 | -29.7% | $20.5M | 0.4% | $7.8 |
| Q3 2024 | 3,744,263 | 0 | – | $40.4M | 0.6% | $10.8 |
| Q2 2024 | 3,744,263 | +2,209,918 | +144.0% | $31.6M | 0.5% | $8.4 |
| Q1 2024 | 1,534,345 | +445,000 | +40.9% | $10.3M | 0.2% | $6.7 |
| Q4 2023 | 1,089,345 | 0 | – | $6.4M | 0.1% | $5.9 |
| Q3 2023 | 1,089,345 | 2,277,000 | -67.6% | $10.6M | 0.2% | $9.8 |
| Q2 2023 | 3,366,345 | +400,000 | +13.5% | $39.9M | 0.9% | $11.8 |
| Q1 2023 | 2,966,345 | 0 | – | $32.0M | 0.7% | $10.8 |
| Q4 2022 | 2,966,345 | 0 | – | $34.3M | 0.7% | $11.6 |
| Q3 2022 | 2,966,345 | 2,910,460 | -49.5% | $44.3M | 0.9% | $14.9 |
| Q2 2022 | 5,876,805 | +4,275,805 | +267.1% | $53.0M | 1.1% | $9.0 |
| Q1 2022 | 1,601,000 | 0 | – | $12.0M | 0.3% | $7.5 |
| Q4 2021 | 1,601,000 | 0 | – | $13.7M | 0.3% | $8.6 |
| Q3 2021 | 1,601,000 | 0 | – | $13.5M | 0.3% | $8.4 |
| Q2 2021 | 1,601,000 | +601,000 | +60.1% | $13.0M | 0.2% | $8.1 |
| Q1 2021 | 1,000,000 | 0 | – | $8.8M | 0.2% | $8.8 |
| Q4 2020 | 1,000,000 | – | – | $11.2M | 0.2% | $11.2 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did DEERFIELD MANAGEMENT COMPANY, L.P. first disclose a COGT position in 13F-HR filings?
DEERFIELD MANAGEMENT COMPANY, L.P. first reported COGENT BIOSCIENCES INC (COGT) on its 13F-HR filing for the period ending 2020-12-31 (Q4 2020). The position has appeared on 23 reported quarters within Pactolio's tracked window.
What was DEERFIELD MANAGEMENT COMPANY, L.P.'s most recent quarter-over-quarter share-count change in COGT?
Between Q1 2026 and Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. reduced its COGT position by 4,037,799 shares (-44.6%), leaving 5,006,104 shares at a market value of $193.7M.
Does the implied price-per-share represent DEERFIELD MANAGEMENT COMPANY, L.P.'s cost basis in COGT?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.